Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, et al.
EFSA Journal (2022) Vol. 20, Iss. 6
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)
José Diogo R. Souza, Júlia Cozar Pacheco, Giordano Novak Rossi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2598-2598
Open Access | Times Cited: 38
Is the potential for bioaccumulation of cannabinoids underestimated? Insights from biomimetic chromatography in cannabinoid exposure evaluation
Krzesimir Ciura, Kamila Jarzyńska, Katarzyna Ewa Greber, et al.
Food and Chemical Toxicology (2025), pp. 115252-115252
Closed Access | Times Cited: 1
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Uncovering the secrets of industrial hemp in food and nutrition: The trends, challenges, and new-age perspectives
Simon Okomo Aloo, Godfrey Mwiti, Louise Ngugi, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 15, pp. 5093-5112
Open Access | Times Cited: 35
Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the European Food Safety Authority (EFSA) Clock Stop Regarding Novel Food Authorisation
Dirk W. Lachenmeier, Constanze Sproll, Stephan G. Walch
Psychoactives (2023) Vol. 2, Iss. 1, pp. 66-75
Open Access | Times Cited: 18
Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety
Beatriz Pires Ferreira, Gustavo Costa, Filipa Mascarenhas‐Melo, et al.
Phytochemistry Reviews (2023) Vol. 22, Iss. 3, pp. 781-828
Open Access | Times Cited: 16
Long-term daily feeding of cannabidiol is well-tolerated by healthy dogs
Sophie Bradley, Scott Young, Anne Marie Bakke, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 20
Safety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerol
Hana Polanská, Kateřina Petrláková, Barbora Papoušková, et al.
Toxicology (2023) Vol. 488, pp. 153460-153460
Closed Access | Times Cited: 12
Healthy cats tolerate long-term daily feeding of Cannabidiol
Jennifer C. Coltherd, Robyn Bednall, Anne Marie Bakke, et al.
Frontiers in Veterinary Science (2024) Vol. 10
Open Access | Times Cited: 4
Exploring the safety of cannabidiol (CBD): A comprehensive in vitro evaluation of the genotoxic and mutagenic potential of a CBD isolate and extract from Cannabis sativa L
Alja Štern, Matjaž Novak, Katja Kološa, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116969-116969
Open Access | Times Cited: 4
A high-fat meal significantly impacts the bioavailability and biphasic absorption of cannabidiol (CBD) from a CBD-rich extract in men and women
Bo Anne Daniëlla Frederique Saals, Tessa H. de Bie, Eral Osmanoglou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hepatic biotransformation of non-psychotropic phytocannabinoids and activity screening on cytochromes P450 and UDP-glucuronosyltransferases
J. Havlasek, Jiřı́ Vrba, Martina Zatloukalová, et al.
Toxicology and Applied Pharmacology (2023) Vol. 476, pp. 116654-116654
Closed Access | Times Cited: 10
Cannabidiol (CBD): Confronting consumers’ expectations of therapeutic benefits with pharmacological reality
Bruno Revol, Julie Bagnolati, Joëlle Micallef, et al.
Therapies (2024) Vol. 79, Iss. 5, pp. 497-504
Closed Access | Times Cited: 3
The Potential of Hemp Extracts to Modify the Course of Oxidative-Stress Related Conditions
Katarina Bijelić, Branislava Srđenović Čonić, Blagoje Prpa, et al.
Plants (2024) Vol. 13, Iss. 12, pp. 1630-1630
Open Access | Times Cited: 3
Usage and health perception of cannabidiol-containing products among the population in Germany: a descriptive study conducted in 2020 and 2021
Johanna Geppert, Julika Lietzow, Stefanie Hessel‐Pras, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, et al.
F1000Research (2023) Vol. 8, pp. 1394-1394
Open Access | Times Cited: 7
The Regulatory Challenges of Placing Dietary Ingredients on the European and US Market
Mark J. Tallon, Doug Kalman
Journal of Dietary Supplements (2024), pp. 1-16
Closed Access | Times Cited: 2
Comprehensive analysis of 19 cannabinoids in commercial CBD oils: concentrations, profiles, and safety implications
Niklas Lindekamp, Stefan Weigel, Benjamin Sachse, et al.
Journal of Consumer Protection and Food Safety (2024) Vol. 19, Iss. 3, pp. 259-267
Open Access | Times Cited: 2
Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
João Luís Q. Simei, José Diogo R. Souza, João Francisco Cordeiro Pedrazzi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1644-1644
Open Access | Times Cited: 2
Hemp-based tea - Impact of preparation technique on major cannabinoids content and consumers' exposure and health risk
Katarina Bijelić, Ljilja Torović, Blagoje Prpa, et al.
Food Control (2023) Vol. 152, pp. 109822-109822
Closed Access | Times Cited: 6
Genotoxicity evaluation of cannabidiol
Rayetta G. Henderson, Brian T. Welsh, Kristen R. Trexler, et al.
Regulatory Toxicology and Pharmacology (2023) Vol. 142, pp. 105425-105425
Open Access | Times Cited: 5
Cannabidiol's impact on drug-metabolization
Claudia Stöllberger, Josef Finsterer
European Journal of Internal Medicine (2023) Vol. 118, pp. 6-13
Closed Access | Times Cited: 5
Cannabidiol safety considerations: Development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use
Rayetta G. Henderson, Melissa Vincent, Brianna N. Rivera, et al.
Regulatory Toxicology and Pharmacology (2023) Vol. 144, pp. 105482-105482
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top